This article was scientifically reviewed by YourDNA
We take the information we share seriously. Review our Editorial Policy Here.
KLOTHO Therapeutics (KTI) is a biotechnology company developing a patent-pending Klotho protein that has great potential to redefine society’s experience with aging.
KTI has worldwide patents pending on versions of modified, recombinant Klotho that can be manufactured using standard cell culture technology.
Powered by Froala Editor
